Diversified Portfolio A&Z Pharmaceutical operates in both consumer health and contract development/manufacturing, presenting cross-sell opportunities between their D-Cal and MFIT Supps nutraceutical lines and AiPing pharmaceutical CDMO services to clients seeking integrated product development and manufacturing.

Global Brand Reach Flagship D-Cal brand claims top ten status in vitamin D and calcium supplements across multiple regions, including China, suggesting potential to leverage existing international distribution to expand D-Cal and related nutritional products into new markets and retailers.

Manufacturing Capabilities AiPing CDMO operations offer end-to-end production from development to launch, enabling partnerships with pharma and nutraceutical brands seeking scalable, compliant manufacturing capacity and rapid time-to-market.

Growth & Investment Recent NYS COVID-19 grant support and a revenue profile in the mid-to-upper hundred millions indicate financial stability and capacity to fund new manufacturing contracts, device partnerships, or co-development deals.

R&D & Education Dedicated research labs and emphasis on education and quality position A&Z as a value-driven partner for innovation projects, clinical data collaborations, and customer education programs that can enhance premium product adoption for retailers and healthcare customers.